Clinical Trial Update: Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating percutaneous reduction of mitral regurgitation in heart failure patients has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Mitral Regurgitation

Snippet

Sponsor: Viacor | Conditions: Heart Failure, Mitral Regurgitation | Phase 2 | Status: SUSPENDED